Leerink Partnrs Lowers Earnings Estimates for Quanterix

Quanterix Co. (NASDAQ:QTRX) – Stock analysts at Leerink Partnrs reduced their FY2024 earnings per share (EPS) estimates for Quanterix in a research report issued on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now forecasts that the company will earn ($0.98) per share for the year, down from their previous forecast of ($0.94). The consensus estimate for Quanterix’s current full-year earnings is ($0.94) per share. Leerink Partnrs also issued estimates for Quanterix’s Q4 2024 earnings at ($0.27) EPS, Q1 2025 earnings at ($0.58) EPS, Q2 2025 earnings at ($0.26) EPS, Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.26) EPS, FY2025 earnings at ($1.33) EPS and FY2026 earnings at ($0.89) EPS.

Quanterix (NASDAQ:QTRX) last issued its earnings results on Monday, December 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%.

Separately, TD Cowen increased their price target on Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a research note on Wednesday, November 13th.

Quanterix Price Performance

Shares of Quanterix stock opened at $10.21 on Thursday. The company’s 50 day moving average price is $11.02 and its two-hundred day moving average price is $12.46. The firm has a market capitalization of $393.29 million, a P/E ratio of -9.63 and a beta of 1.33. Quanterix has a fifty-two week low of $8.21 and a fifty-two week high of $29.70.

Institutional Investors Weigh In On Quanterix

Several hedge funds have recently added to or reduced their stakes in QTRX. Hsbc Holdings PLC raised its stake in shares of Quanterix by 34.7% during the second quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock valued at $164,000 after acquiring an additional 3,279 shares during the last quarter. Emerald Mutual Fund Advisers Trust raised its position in Quanterix by 0.8% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company’s stock worth $7,300,000 after purchasing an additional 4,406 shares during the last quarter. nVerses Capital LLC acquired a new position in Quanterix during the 3rd quarter worth about $60,000. Janney Capital Management LLC lifted its holdings in Quanterix by 33.6% during the 3rd quarter. Janney Capital Management LLC now owns 23,553 shares of the company’s stock worth $305,000 after buying an additional 5,930 shares during the period. Finally, American Century Companies Inc. grew its position in shares of Quanterix by 14.5% in the 2nd quarter. American Century Companies Inc. now owns 56,145 shares of the company’s stock valued at $742,000 after buying an additional 7,118 shares during the last quarter. 86.48% of the stock is currently owned by institutional investors and hedge funds.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.